-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Head-To-Head Contrast: SNDL (NASDAQ:SNDL) & Curaleaf (OTCMKTS:CURLF)
Head-To-Head Contrast: SNDL (NASDAQ:SNDL) & Curaleaf (OTCMKTS:CURLF)
Curaleaf (OTCMKTS:CURLF – Get Rating) and SNDL (NASDAQ:SNDL – Get Rating) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Profitability
This table compares Curaleaf and SNDL's net margins, return on equity and return on assets.
Get Curaleaf alerts:| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
Insider & Institutional Ownership
0.1% of Curaleaf shares are held by institutional investors. Comparatively, 10.7% of SNDL shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings for Curaleaf and SNDL, as reported by MarketBeat.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
Curaleaf currently has a consensus price target of $11.72, suggesting a potential upside of 196.02%. SNDL has a consensus price target of $5.20, suggesting a potential upside of 123.18%. Given Curaleaf's stronger consensus rating and higher probable upside, equities analysts plainly believe Curaleaf is more favorable than SNDL.
Valuation & Earnings
This table compares Curaleaf and SNDL's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.21 billion | 2.03 | -$101.73 million | ($0.18) | -22.00 |
| SNDL | $44.78 million | 8.64 | -$183.82 million | ($0.96) | -2.43 |
Curaleaf has higher revenue and earnings than SNDL. Curaleaf is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.
Summary
Curaleaf beats SNDL on 9 of the 12 factors compared between the two stocks.
About Curaleaf
(Get Rating)
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of November 22, 2022, it operated 144 dispensaries and 29 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
About SNDL
(Get Rating)
SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. Its brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. The company was founded by Stanley J. Swiatek on August 19, 2006 and is headquartered in Calgary, Canada.
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
Curaleaf (OTCMKTS:CURLF – Get Rating) and SNDL (NASDAQ:SNDL – Get Rating) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Curaleaf(場外交易代碼：CURLF-GET Rating)和SNDL(納斯達克：SNDL-GET Rating)都是非必需消費品公司，但哪種業務更好？我們將根據這兩家公司的風險、估值、收益、股息、機構所有權、盈利能力和分析師的建議進行對比。
Profitability
盈利能力
This table compares Curaleaf and SNDL's net margins, return on equity and return on assets.
下表比較了Curaleaf和SNDL的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 庫拉利夫 | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
Insider & Institutional Ownership
內部人與機構所有權
0.1% of Curaleaf shares are held by institutional investors. Comparatively, 10.7% of SNDL shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Curaleaf 0.1%的股份由機構投資者持有。相比之下，SNDL 10.7%的股份由機構投資者持有。強大的機構持股表明，大型基金管理公司、對衝基金和捐贈基金相信，一家公司有望實現長期增長。
Analyst Recommendations
分析師建議
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 庫拉利夫 | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
Curaleaf currently has a consensus price target of $11.72, suggesting a potential upside of 196.02%. SNDL has a consensus price target of $5.20, suggesting a potential upside of 123.18%. Given Curaleaf's stronger consensus rating and higher probable upside, equities analysts plainly believe Curaleaf is more favorable than SNDL.
Curaleaf目前的普遍目標價為11.72美元，這意味着潛在的上行空間為196.02%。SNDL的普遍目標價為5.2美元，暗示潛在上漲123.18%。考慮到Curaleaf更強的共識評級和更高的上行可能性，股票分析師顯然認為Curaleaf比SNDL更有利。
Valuation & Earnings
估值與收益
This table compares Curaleaf and SNDL's revenue, earnings per share (EPS) and valuation.
該表比較了Curaleaf和SNDL的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.21 billion | 2.03 | -$101.73 million | ($0.18) | -22.00 |
| SNDL | $44.78 million | 8.64 | -$183.82 million | ($0.96) | -2.43 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 庫拉利夫 | 12.1億美元 | 2.03 | -1.0173億美元 | ($0.18) | -22.00 |
| SNDL | 4478萬美元 | 8.64 | -1.8382億美元 | ($0.96) | -2.43 |
Curaleaf has higher revenue and earnings than SNDL. Curaleaf is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.
Curaleaf的收入和收益高於SNDL。Curaleaf的市盈率低於SNDL，表明它目前是兩隻股票中更負擔得起的一隻。
Summary
摘要
Curaleaf beats SNDL on 9 of the 12 factors compared between the two stocks.
Curaleaf在兩隻股票比較的12個因素中有9個超過了SNDL。
About Curaleaf
關於Curaleaf
(Get Rating)
(獲取評級)
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of November 22, 2022, it operated 144 dispensaries and 29 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Curaleaf Holdings，Inc.在美國經營着一家大麻運營商。它分為兩個部門，大麻業務和非大麻業務。大麻業務部門通過零售和批發渠道從事大麻的生產和銷售。非大麻業務部門提供專業服務，包括種植、加工和零售知識以及後臺管理、知識產權許可、房地產租賃服務，以及根據管理服務協議向醫用和成人用大麻許可證持有者提供貸款設施。它提供鮮花、預卷、花莢和乾草汽化器墨盒；用於汽化的濃縮物，如預填充的汽化器墨盒和一次性汽化器筆；以及用於塗抹的濃縮物，包括蒸餾液滴管、薄荷、外用香油和乳液、酊劑、含片、膠囊和可食用食品。該公司還提供以大麻為基礎的CBD產品。截至2022年11月22日，該公司在美國21個州經營着144家藥房和29個種植地點。該公司成立於2010年，總部位於馬薩諸塞州韋克菲爾德。
About SNDL
關於SNDL
(Get Rating)
(獲取評級)
SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. Its brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. The company was founded by Stanley J. Swiatek on August 19, 2006 and is headquartered in Calgary, Canada.
SNDL，Inc.是一家獲得許可的生產商，使用最先進的室內設施生產小批量大麻。其品牌組合包括Top Leaf、Sunial Cannabis、Palmetto和Grands。太陽錶盤還經營着精靈葉零售橫幅。該公司由Stanley J.Swiatek於2006年8月19日創立，總部設在加拿大卡爾加里。
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
接受Curaleaf Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Curaleaf和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧